NeribiOm Biotechnology: from neurobiotics selection to the production of Live Biotherapeutics Products
Probiotics are alive microorganisms and their efficacy depends on their physiology and viability. The production of probiotics for therapeutic uses (Live Biotherapeutics Products, LBP) including bioengineered probiotic bacteria strains requires expertise and stringent quality control throughout the process.
Only a few companies in the world possess the know-how and industrial capability to produce and process living anaerobic bacteria and these expertises are provided by NeribiOm.
Therapeutics applications of LBP claimed by Neribiom is supported by our strong expertise on the physiopathology of CNS deseases and our knowledge on microbiome applications including gut-brain axis.